# Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine

> **NCT03961438** · PHASE1 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 24 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
- **BIOLOGICAL:** ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes

## Key facts

- **NCT ID:** NCT03961438
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-15
- **Primary completion:** 2022-06-06
- **Final completion:** 2023-04-17
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961438, "Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03961438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*